«12345›»Seite
5 articles with references, page 5 of 5

cme

The Pathophysiology, Diagnosis and Treatment of Constipation

Dtsch Arztebl Int 2009; 106(25): 424-31; DOI: 10.3238/arztebl.2009.0424

Müller-Lissner, S

1. Everhart JE, Go VLW, Johannes RS, Fitzsimmons SC, Roth HP, White LR: A longitudinal survey of self-reported bowel habits in the United States. Dig Dis Sci 1989; 34: 1153–62. MEDLINE
2. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC: Functional Bowel Disorders. Gastroenterology 2006; 130: 1480–91. MEDLINE
3. Müller-Lissner SA, Kamm MA, Scarpignato C, Wald A: Myths and misconceptions about chronic constipation. Amer J Gastroenterol 2005; 100: 232–42. MEDLINE
4. Müller-Lissner SA: The effect of wheat bran on stool weight and gastrointestinal transit time. A meta-analysis. Br med J 1988; 296: 615–17. MEDLINE
5. Voderholzer WA, Schatke W, Mühldorfer BE, Klauser AG, Birkner B, Müller-Lissner SA: Clinical response to dietary fiber treatment in chronic constipation. Am J Gastroenterol 1997, 92: 95–98. MEDLINE
6. Meissner W, Leyendecker P, Müller-Lissner S, et al.: A randomised controlled trial with prolonged-release oral oxycodone and naloxone to prevent and reverse opioid-induced constipation. Eur J Pain. 2009; 13: 56–64. MEDLINE
7. Thomas J, Karver S, Cooney GA, et al.: Methylnaltrexone for opioid-induced constipation in advanced illness. N Engl J Med 2008; 358: 2332–43. MEDLINE
8. Bharoucha AE; Wald A, Enck P, Rao S: Functional Anorectal Disorders. Gastroenterology 2006; 130: 1510–18. MEDLINE
9. Francis CY, Whorwell P: Bran and irritable bowel syndrome: time for reappraisal. Lancet 1994; 344: 39–40. MEDLINE
10. Goei R: Anorectal function in patients with defecation disorders and asymptomatic subjects: evaluation with defecography. Radiology 1990; 174: 121–3. MEDLINE
11. Dennison C, Prasad M, Lloyd A, Bhattacharyya SK, Dhawan R, Coyne K: The health-related quality of life and economic burden of constipation. Pharmacoeconomics 2005; 23: 461–76. MEDLINE
12. Cummings JH, Southgate DAT, Branch W, Houston H, Jenkins DJA, James WPT: Colonic response to dietary fibre from carrot, cabbage, apple, bran, and guar gum. Lancet 1978; 1: 5–8. MEDLINE
13. Müller-Lissner SA: What has happened to the cathartic colon? Gut 1996; 39: 486–8. MEDLINE
14. Kinnunen O, Salokannel J: Constipation in the elderly long-stay patients: its treatment by magnesium hydroxide and bulk laxative. Ann Clin Res 1987; 19: 321–3. MEDLINE
15. Attar A, Lémann M, Ferguson A et al.: Comparison of a low dose polyethylene glycol electrolyte solution with lactulose for treatment of chronic constipation. Gut 1999; 44: 226–30. MEDLINE
16. Passmore AP, Wilson-Davies K, Stoker C, Scott ME: Chronic constipation in long-stay elderly patients: a comparison of lactulose and a senna-fibre combination. BMJ 1993; 307: 769–71. MEDLINE
17. Kienzle-Horn S, Vix JM, Schuijt C, Peil H, Jordan CC, Kamm MA: Comparison of bisacodyl and sodium picosulfate in the treatment of chronic constipation. Curr Med Res Opinion 2007; 23: 891–9. MEDLINE
18. Bengtsson M, Ohlsson B: Retrospective study of long-term treatment with sodium picosulfate. Eur J Gastroenterol Hepatol 2004; 16: 433–4.
19. Sonnenberg A, Müller AD: Constipation and cathartics as risk factors of colorectal cancer: a meta-analysis. Pharmacology 1993; 47(Suppl 1): 224–33. MEDLINE
20. Tack J, Müller-Lissner S: Treatment of chronic constipation: current pharmacologic approaches and future directions. Clin Gastroenterol Hepatol 2009; 7: 502–8. MEDLINE
21. Johanson JF, Morton D, Geenen J, Ueno R: Multicenter, 4-week, double-blind, randomized, placebo-controlled trial of lubiprostone, a locally-acting type-2 chloride channel activator, in patients with chronic constipation. Am J Gastroenterol 2008; 103: 170–7. MEDLINE
22. Andresen V, Camilleri M, Busciglio IA et al.: Effect of 5 days linaclotide on transit and bowel function in females with constipation-predominant irritable bowel syndrome. Gastroenterology 2007; 133: 761–8. MEDLINE
23. Chiarioni G, Whitehead WE, Pezza V, Morelli A, Bassotti G: Biofeedback is superior to laxatives for normal transit constipation due to pelvic floor dyssynergia. Gastroenterology 2006; 130: 657–64. MEDLINE
24. Emmanuel AV, Kamm MA: Response to a behavioural treatment, biofeedback, in constipated patients is associated with improved gut transit and autonomic innervation. Gut. 2001; 49: 214–9. MEDLINE
25. Mason HJ, Serrano-Ikkos E, Kamm MA: Psychologic morbidity in women with chronic idiopathic constipation. Am J Gastroenterol 2000; 95: 2852–7. MEDLINE